Pune Maharashtra, India

Ganpati Powar Rajendra


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ganpati Powar Rajendra

Introduction

Ganpati Powar Rajendra is a notable inventor based in Pune, Maharashtra, India. He has made significant contributions to the field of chemistry, particularly in the synthesis of complex compounds. His work focuses on developing methods that are both economical and scalable, which is crucial for pharmaceutical applications.

Latest Patents

Rajendra holds a patent for "Methods, processes and intermediates for preparing chroman compounds." This patent describes an innovative method to synthesize the Calcium sensing receptor (CaSR) modulating agent, specifically 2-methyl-5-((2R,4S)-2-((((R)-1-(naphthalen-1-yl)ethyl)amino)methyl)chroman-4-yl)benzoic acid. The patent also covers its intermediates and pharmaceutically acceptable salts. The methods outlined in this patent are essential for the synthesis of compounds that may serve as intermediates in the production of the aforementioned modulating agent.

Career Highlights

Rajendra is currently associated with Lupin, Inc., a prominent player in the pharmaceutical industry. His role at the company allows him to apply his innovative ideas and contribute to the development of new therapeutic agents. His work is characterized by a commitment to advancing pharmaceutical science through practical and effective solutions.

Collaborations

Rajendra has collaborated with several professionals in his field, including Rajender Kumar Kamboj and Kamlesh Jyotindra Padiya. These collaborations enhance the research and development efforts at Lupin, Inc., fostering an environment of innovation and teamwork.

Conclusion

Ganpati Powar Rajendra's contributions to the field of chemistry and pharmaceuticals are noteworthy. His patent on chroman compounds exemplifies his innovative spirit and dedication to advancing medical science. Through his work at Lupin, Inc., he continues to make strides in the development of important pharmaceutical agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…